Jun 02, 2025
Endo Champions Men's Health Month with Education, Awareness, and Outreach
May 15, 2025
Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration
May 07, 2025
Endo Reports First-Quarter 2025 Financial Results and Reaffirms 2025 Financial Guidance
Mar 26, 2025
Endo Launches Spatial Computing Simulator to Create a Fully Immersive Learning Environment for Hand Specialists
Mar 24, 2025
Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Mar 13, 2025
Endo Reports Fourth-Quarter and Full-Year 2024 Financial Results
Mar 13, 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mar 11, 2025
Endo Announces Divestiture of International Pharmaceuticals Business
Mar 10, 2025
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
Feb 27, 2025
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women's Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
Feb 17, 2025
Endo Launches "Steve's Journey," the First Branded Dupuytren's Contracture Commercial for XIAFLEX® (collagenase clostridium histolyticum)
Jan 13, 2025
Endo Launches New Peyronie's Disease Campaign: I Got Somebody
Dec 10, 2024
Endo Launches Doxycycline for Injection, USP
Dec 09, 2024
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
Nov 20, 2024
John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
Nov 18, 2024
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Oct 29, 2024
Endo Announces Successful Term Loan Repricing
Oct 18, 2024
Endo Presents Data at the American Society of Podiatric Surgeons (ASPS) Annual Surgical Conference
Oct 17, 2024
Endo Announces Seven New Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
Oct 15, 2024
Endo to Host Investor Call on Third-Quarter 2024 Financial Results